Literature DB >> 12957237

The effects of habitual caffeine use on cognitive change: a longitudinal perspective.

M P J van Boxtel1, J A J Schmitt, H Bosma, J Jolles.   

Abstract

The efficiency of higher cortical functions, such as memory and speed of complex information processing, tends to decrease with advancing age in normal healthy individuals. Recently, a high habitual intake of caffeine was found associated with better verbal memory performance and psychomotor speed in several cross-sectional population studies. We tested the hypothesis that habitual caffeine intake can reduce or postpone age-related cognitive decline in healthy adults. For this purpose, the cognitive performance of all participants in the Maastricht Aging Study (MAAS), aged between 24 and 81 years, was reassessed after 6 years. Information on the intake of caffeine-containing beverages was available from the baseline questionnaire. After 6 years, 1376 (75.6%) individuals were available for reassessment. After correction for demographic characteristics, baseline performance and health status, there were small albeit significant associations between the overall estimated caffeine intake at baseline and the 6-year change in complex motor speed (motor choice reaction time). The earlier found association between caffeine intake and verbal memory performance was not apparent in this longitudinal study. These results imply that the longitudinal effect of habitual caffeine intake is limited and will not promote a substantial reduction in age-related cognitive decline at a population level.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957237     DOI: 10.1016/s0091-3057(03)00171-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  23 in total

1.  Caffeine intake and cognitive functions in children.

Authors:  Han Zhang; Zu Xuan Lee; Anqi Qiu
Journal:  Psychopharmacology (Berl)       Date:  2020-06-29       Impact factor: 4.530

Review 2.  Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer's disease.

Authors:  A J Carman; P A Dacks; R F Lane; D W Shineman; H M Fillit
Journal:  J Nutr Health Aging       Date:  2014-04       Impact factor: 4.075

Review 3.  Impact of Coffee and Cacao Purine Metabolites on Neuroplasticity and Neurodegenerative Disease.

Authors:  Simonetta Camandola; Natalie Plick; Mark P Mattson
Journal:  Neurochem Res       Date:  2018-02-08       Impact factor: 3.996

Review 4.  Attention, psychomotor functions and age.

Authors:  Konrad Wolfgang Kallus; Jeroen A J Schmitt; David Benton
Journal:  Eur J Nutr       Date:  2005-12       Impact factor: 5.614

Review 5.  Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review.

Authors:  F Panza; V Solfrizzi; M R Barulli; C Bonfiglio; V Guerra; A Osella; D Seripa; C Sabbà; A Pilotto; G Logroscino
Journal:  J Nutr Health Aging       Date:  2015-03       Impact factor: 4.075

Review 6.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

7.  The role of adenosine in Alzheimer's disease.

Authors:  Anisur Rahman
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 8.  Epidemiologic evidence of a relationship between tea, coffee, or caffeine consumption and cognitive decline.

Authors:  Lenore Arab; Faraz Khan; Helen Lam
Journal:  Adv Nutr       Date:  2013-01-01       Impact factor: 8.701

9.  Caffeine and alcohol intakes and overall nutrient adequacy are associated with longitudinal cognitive performance among U.S. adults.

Authors:  May A Beydoun; Alyssa A Gamaldo; Hind A Beydoun; Toshiko Tanaka; Katherine L Tucker; Sameera A Talegawkar; Luigi Ferrucci; Alan B Zonderman
Journal:  J Nutr       Date:  2014-04-17       Impact factor: 4.798

Review 10.  Psychostimulants and cognition: a continuum of behavioral and cognitive activation.

Authors:  Suzanne Wood; Jennifer R Sage; Tristan Shuman; Stephan G Anagnostaras
Journal:  Pharmacol Rev       Date:  2013-12-16       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.